The Multiple Myeloma Research Foundation Inc

Analysis

The Multiple Myeloma Research Foundation Inc is a registered charity in United States, based in Norwalk, CT. It received its IRS tax-exemption ruling in March 1998, 28 years ago. Its declared purposes cover diseases, disorders and medical disciplines, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, The Multiple Myeloma Research Foundation Inc reported income of $34.0m and spending of $41.9m, spending 123% of what it took in. Across the 5 years on record, from December 2019 to December 2023, income fell from $44.0m to $34.0m (-23%), an average of -6.3% a year. The sharpest change came in the year to December 2021, when income rose by 58%. Over the whole period it spent 94% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, The Multiple Myeloma Research Foundation Inc sits at the 91st percentile: it is larger than about 91% of them. Against every charity in United States with reported income it ranks in the 98th percentile, and in the 98th percentile within CT. Charities of a similar size with the same main cause include Easterseals Arkansas ($33.9m), St Francis House Nwa Inc ($34.0m) and Orlando Health Foundation Inc ($33.9m).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 91% and program service revenue 3.8% of the total. Compensation of current officers, directors and key employees was $3.7m (8.8% of expenses). Other salaries and wages came to $6.4m. At year end it held assets of $80.2m against liabilities of $23.9m, net assets of $56.3m. It reported 78 employees.